Search Results - "Newton, Thomas C."

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Management of Hyperhemolysis in β-thalassemia With Multiple Immunosuppressives, Including Complement Blockade

    Management of Hyperhemolysis in β-thalassemia With Multiple Immunosuppressives, Including Complement Blockade by Zanetti, Richard C., Vasta, Lauren M., Romanelli, Kristen, Newton, Thomas C.

    Published in Journal of pediatric hematology/oncology (01-11-2021)
    “…Hyperhemolysis is a life-threatening condition of exaggerated hemolysis of red blood cells which occurs in patients receiving chronic transfusion therapy. We…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Subcutaneous immunoglobulin therapy in an 11-year-old patient with common variable immunodeficiency and von Willebrand disease

    Subcutaneous immunoglobulin therapy in an 11-year-old patient with common variable immunodeficiency and von Willebrand disease by Arora, Rajiv, MD, Newton, Thomas C., MD, Nelson, Michael R., MD, PhD

    Published in Annals of Allergy, Asthma & Immunology (01-10-2007)
    “…Background Subcutaneous immunoglobulin (SCIG) is an option for replacement therapy in patients with humoral immune deficiencies. Objective To describe a…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Comparison of the Side Populations in Pretreatment and Postrelapse Neuroblastoma Cell Lines

    Comparison of the Side Populations in Pretreatment and Postrelapse Neuroblastoma Cell Lines by Newton, Thomas C., Wolcott, Karen, Roberts, Stephen S.

    Published in Translational oncology (01-08-2010)
    “…Cancer stem-like cells have been identified in both primary tumors and in cell lines and seem to have a high degree of inherent resistance to traditional…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Management of Hyperhemolysis in β-thalassemia With Multiple Immunosuppressives, Including Complement Blockade

    Management of Hyperhemolysis in β-thalassemia With Multiple Immunosuppressives, Including Complement Blockade by Zanetti, Richard C., Vasta, Lauren M., Romanelli, Kristen, Newton, Thomas C.

    Published in Journal of pediatric hematology/oncology (20-01-2021)
    “…Hyperhemolysis is a life-threatening condition of exaggerated hemolysis of red blood cells which occurs in patients receiving chronic transfusion therapy. We…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    Abstract 1442: Side population analysis and gene expression profiling identify Notch pathway genes in neuroblastoma

    Abstract 1442: Side population analysis and gene expression profiling identify Notch pathway genes in neuroblastoma by Mendonca, Maria Cecilia F., Newton, Thomas C., Sholler, Giselle, Roberts, Stephen S.

    Published in Cancer research (Chicago, Ill.) (15-04-2012)
    “…Abstract High-risk neuroblastoma (NB) has a very poor prognosis. Upon relapse, NB is chemotherapy-resistant and almost universally fatal. Cancer stem-like…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  6. 6
    Comparison of the Side Populations in Pretreatment and Postrelapse Neuroblastoma Cell Lines1

    Comparison of the Side Populations in Pretreatment and Postrelapse Neuroblastoma Cell Lines1 by Newton, Thomas C, Wolcott, Karen, Roberts, Stephen S

    Published in Translational oncology (01-08-2010)
    “…Cancer stem-like cells have been identified in both primary tumors and in cell lines and seem to have a high degree of inherent resistance to traditional…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: